Literature DB >> 17531589

Changes in coronary anatomy and physiology after heart transplantation.

Atsushi Hirohata1, Mamoo Nakamura, Katsuhisa Waseda, Yasuhiro Honda, David P Lee, Randall H Vagelos, Sharon A Hunt, Hannah A Valantine, Paul G Yock, Peter J Fitzgerald, Alan C Yeung, William F Fearon.   

Abstract

Cardiac allograft vasculopathy (CAV) is a progressive process involving the epicardial and microvascular coronary systems. The timing of the development of abnormalities in these 2 compartments and the correlation between changes in physiology and anatomy are undefined. The invasive evaluation of coronary artery anatomy and physiology with intravascular ultrasound, fractional flow reserve, coronary flow reserve, and the index of microcirculatory resistance (IMR) was performed in the left anterior descending coronary artery during 151 angiographic evaluations of asymptomatic heart transplant recipients from 0 to >5 years after heart transplantation (HT). There was no angiographic evidence of significant CAV, but during the first year after HT, fractional flow reserve decreased significantly (0.89 +/- 0.06 vs 0.85 +/- 0.07, p = 0.001), and percentage plaque volume derived by intravascular ultrasound increased significantly (15.6 +/- 7.7% to 22.5 +/- 12.3%, p = 0.0002), resulting in a significant inverse correlation between epicardial physiology and anatomy (r = -0.58, p <0.0001). The IMR was lower in these patients compared with those > or =2 years after HT (24.1 +/- 14.3 vs 29.4 +/- 18.8 units, p = 0.05), suggesting later spread of CAV to the microvasculature. As the IMR increased, fractional flow reserve increased (0.86 +/- 0.06 to 0.90 +/- 0.06, p = 0.0035 comparing recipients with IMRs < or =20 to those with IMRs > or =40), despite no difference in percentage plaque volume (21.0 +/- 11.2% vs 20.5 +/- 10.5%, p = NS). In conclusion, early after HT, anatomic and physiologic evidence of epicardial CAV was found. Later after HT, the physiologic effect of epicardial CAV may be less, because of increased microvascular dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17531589      PMCID: PMC5544934          DOI: 10.1016/j.amjcard.2007.01.039

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  G S Mintz; S E Nissen; W D Anderson; S R Bailey; R Erbel; P J Fitzgerald; F J Pinto; K Rosenfield; R J Siegel; E M Tuzcu; P G Yock
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  Coronary thermodilution to assess flow reserve: experimental validation.

Authors:  B De Bruyne; N H Pijls; L Smith; M Wievegg; G R Heyndrickx
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

3.  Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve.

Authors:  Martin K C Ng; Alan C Yeung; William F Fearon
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

4.  Coronary Doppler measurements do not predict progression of cardiac allograft vasculopathy: analysis by serial intracoronary Doppler, dobutamine stress echocardiography, and intracoronary ultrasound.

Authors:  Andreas König; Christoph H Spes; Thomas M Schiele; Johannes Rieber; Hans U Stempfle; Bruno Meiser; Karl Theisen; Harald Mudra; Bruno Reichart; Volker Klauss
Journal:  J Heart Lung Transplant       Date:  2002-08       Impact factor: 10.247

5.  Novel index for invasively assessing the coronary microcirculation.

Authors:  William F Fearon; Leora B Balsam; H M Omar Farouque; Anthony D Caffarelli; Robert C Robbins; Peter J Fitzgerald; Paul G Yock; Alan C Yeung
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

6.  Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study).

Authors:  William F Fearon; Mamoo Nakamura; David P Lee; Mehrdad Rezaee; Randall H Vagelos; Sharon A Hunt; Peter J Fitzgerald; Paul G Yock; Alan C Yeung
Journal:  Circulation       Date:  2003-09-08       Impact factor: 29.690

7.  Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study.

Authors:  William F Fearon; Atsushi Hirohata; Mamoo Nakamura; Helen Luikart; David P Lee; Randall H Vagelos; Sharon A Hunt; Hannah A Valantine; Peter J Fitzgerald; Paul G Yock; Alan C Yeung
Journal:  J Heart Lung Transplant       Date:  2006-05-24       Impact factor: 10.247

8.  Progressive deterioration of coronary flow reserve after heart transplantation.

Authors:  W Mazur; J N Bitar; J B Young; A A Khalil; S Vardan; B C Short; J M Rivera; A E Raizner; J A Farmer; W A Zoghbi; N S Kleiman
Journal:  Am Heart J       Date:  1998-09       Impact factor: 4.749

9.  Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.

Authors:  F G St Goar; F J Pinto; E L Alderman; H A Valantine; J S Schroeder; S Z Gao; E B Stinson; R L Popp
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

10.  Influence of intimal thickening on coronary blood flow responses in orthotopic heart transplant recipients. A combined intravascular Doppler and ultrasound imaging study.

Authors:  E A Caracciolo; T L Wolford; R D Underwood; T J Donohue; R G Bach; L W Miller; M J Kern
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

View more
  8 in total

Review 1.  Diagnosis and management of coronary allograft vasculopathy in children and adolescents.

Authors:  Nathalie Dedieu; Gerald Greil; James Wong; Matthew Fenton; Michael Burch; Tarique Hussain
Journal:  World J Transplant       Date:  2014-12-24

Review 2.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

3.  Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.

Authors:  Yuhei Kobayashi; William F Fearon; Yasuhiro Honda; Shigemitsu Tanaka; Vedant Pargaonkar; Peter J Fitzgerald; David P Lee; Marcia Stefanick; Alan C Yeung; Jennifer A Tremmel
Journal:  JACC Cardiovasc Interv       Date:  2015-09       Impact factor: 11.195

4.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

Review 5.  Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.

Authors:  Robin Som; Peter J Morris; Simon R Knight
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

Review 6.  Endothelial dysfunction and cardiac allograft vasculopathy.

Authors:  Monica Colvin-Adams; Nonyelum Harcourt; Daniel Duprez
Journal:  J Cardiovasc Transl Res       Date:  2012-11-08       Impact factor: 4.132

Review 7.  The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy.

Authors:  Maciej Dyrbuś; Mariusz Gąsior; Bożena Szyguła-Jurkiewicz; Piotr Przybyłowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-04-03       Impact factor: 1.426

8.  Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.

Authors:  Sakura Nagumo; Emanuele Gallinoro; Alessandro Candreva; Takuya Mizukami; Giovanni Monizzi; Monika Kodeboina; Sofie Verstreken; Riet Dierckx; Ward Heggermont; Jozef Bartunek; Marc Goethals; Dimitri Buytaert; Bernard De Bruyne; Jeroen Sonck; Carlos Collet; Marc Vanderheyden
Journal:  J Interv Cardiol       Date:  2020-07-12       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.